CPDD Ongoing Updates and Resources Related to Executive Orders

The Latest  News And Statements

Advocacy 101 Workshop

Advocacy 101 Workshop

The CPDD Public Policy Committee will host an Advocacy 101 Workshop at this year’s 88th Annual Scientific Meeting, offering attendees a practical introduction to effective civic engagement and advocacy in the field of substance use research and policy. This session is designed for newcomers looking to strengthen their ability to communicate with policymakers, translate science into impact, and advance evidence-based solutions. Join the coversation and register for the Annual Meeting here.

read more
CPDD Advocacy Day 2026: Science in Action on Capitol Hill

CPDD Advocacy Day 2026: Science in Action on Capitol Hill

This year, 32 College members from 17 states met with congressional offices to underscore a unified message: strong federal support for substance use and addiction research is essential to improving public health nationwide. The conversations reflected both urgency and opportunity, highlighting the key priorities CPDD members find foundational in their research, field, and community. Sustaining Strong Federal Research Funding CPDD members thanked their Congressional representatives for their...

read more
2026 CPDD Hill Informational Flyers

2026 CPDD Hill Informational Flyers

CPDD’s 2026 informational flyers and white papers are designed to clearly communicate key priorities in SUD and  addiction science and policy. These resources provide an accessible overview of current research efforts, critical funding needs, particularly for NIDA, and the broader policy landscape impacting substance use prevention, treatment, and recovery. They also include key data points, legislative updates, and actionable steps to help stakeholders effectively engage with policymakers and...

read more

Letter on Dosing Limits for Cannabis

Dr. Ryan Vandry, a member of CPDD, has released new, science-driven recommendations to help guide federal policy on hemp-derived cannabinoid products, emphasizing a balanced approach that protects public health while preserving access to beneficial therapies. Developed in concert with leading scientists in the field of cannabis research and pharmacology, the recommendations address growing concerns around unregulated, high-dose intoxicating cannabinoid products while recognizing the important...

read more
CPDD’s Response to NIH Indirect Cost Rate Changes & How You Can Help

CPDD’s Response to NIH Indirect Cost Rate Changes & How You Can Help

CPDD is aware of the Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates, released late Friday night. We are actively reviewing its implications to assess the impact on NIH-funded research, universities, and the broader scientific community.   We recognize the urgency of this issue and the significant consequences of the indirect cost rate cap, particularly in sustaining research institutions, driving innovation, and...

read more
CPDD Community Update: Addressing NIH Program Changes and Ongoing Support

CPDD Community Update: Addressing NIH Program Changes and Ongoing Support

CPDD Community Update: Addressing NIH Program Changes and Ongoing Support We understand that the recent announcement regarding the halt of NIH programs, external communications, and travel restrictions has created a great deal of concern and uncertainty within the CPDD community. These changes are likely to impact not only ongoing projects but also future planning and collaborations. We want to acknowledge the challenges that many of our colleagues, researchers, and partners are currently...

read more

EXECUTIVE ORDERS, LEGISLATIVE RESOURCES AND GOVENMENT MEMOS

SEARCHABLE OPM MEMOS DATABASE
CONSISTENTLY UPDATED